Rosetta Genomics Ltd. engages in the provision of therapeutic, diagnostic product development, and medical research services. The firm is marketing and selling over four diagnostic tests based on its microRNA technologies, which include RosettaGX Cancer Origin, mi-LUNG, mi-KIDNEY, and RosettaGX Reveal. The firm's therapeutic pipeline consists of the projects, which include Rimonim Consortium and Magneton Project. The firm focuses on developing a diagnostic assay, RosettaGX Reveal V2. The company is also focusing on developing Bladder cancer risk stratification.
9명의 애널리스트가 ROSGQ에 대해 제공한 주식 평가를 기반으로 Dec 01, 2021에 업데이트됨
Strong Buy
Strong buy
3
Buy
5
Hold
1
Sell
0
Strong sell
0
Leveraging in-depth analyst evaluations, we have synthesized critical insights from expert assessments to deliver a robust outlook for ROSGQ. Our analysts highlight strong fundamentals and favorable market sentiment, positioning ROSGQ for significant upside potential in the near term. Based on this comprehensive expert analysis, we maintain a highly optimistic view of this stock. Our conclusion: ROSGQ is a Strong Buy candidate.
ROSGQ stock price ended at $0 on 수요일, after rising NaN%
On the latest trading day Jan 07, 2026, the stock price of ROSGQ rose by NaN%, climbing from $0.00 to $0.00. During the session, the stock saw a volatility of NaN%, with prices oscillating between a daily low of $0.00 and a high of $0.00. Notably, trading volume dropped by 4.6K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 5.0K shares were traded, equating to a market value of approximately --.
ROSGQ 기술적 시그널
기술적 시그널 요약
구매 신호 0
중립 신호 6
매도 신호 1
Strong Sell
Sell
Neutral
Buy
Strong Buy
ROSGQ은 현재 0개의 매수 신호와 1개의 매도 신호를 보이고 있습니다. 이 주식은 12:00 AM 이후로 상승 추세 상태에 있으며, 이 기간 동안 총 가격 변동률은 --입니다. 전반적으로 기술적 지표들은 중기적으로 Sell 전망을 나타내고 있습니다.
ROSGQ에 대한 강세/약세 신호
이동평균, RSI, MACD, 거래량 등 핵심 지표를 분석하여 ROSGQ 의 강세/약세 시그널을 생성합니다. 이 인사이트를 활용해 더 현명한 투자 결정을 내리세요.